F 0554
Allow residents to self-administer drugs if determined clinically appropriate.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview and record review, the facility failed to ensure residents were assessed for the ability
to self administer medications. This failure affects two of residents (R54, R333) reviewed for medication use
on the sample list of 30.
Residents Affected - Few
Findings include:
1. R54's admission Record shows R54 was admitted on [DATE] with diagnoses including
gout, right shoulder and left knee pain, and obsessive-compulsive disorder. R54's 12/03/2022
cognitive function care plan showed she has impaired cognitive function related to a diagnosis
of dementia, and her [Minimum Data Set] (MDS) scoring does not reflect cognitive fluctuations
and forgetfulness that is observed by staff.
On 08/22/2023 at 10:29 AM, R54 had an unlabeled tube of topical menthol pain reliever gel and
an antifungal powder container on her nightstand on the right side of her bed.
On 8/22/2023 at 10:30 AM, R54 said she regularly bought the menthol gel from an online
retailer. R54 said she ordered the medication so she can always have and use it when she wanted
to. R54 said she uses the gel on any part of her body that is hurting and she cannot remember
how many times a day she uses it. R54 said she uses the antifungal powder on her groin after
going to the bathroom.
On 08/24/2023 at 09:55 AM, V2 (DON-Director of Nursing) said it is the facility's policy that nurses
will administer medications. V2 stated there are concerns if medications are kept at the bedside without an
assessment and physician orders, including a risk for the patient to self-administer medications
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
146173
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
146173
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/25/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Springs at Monarch Landing, The
2308 North Route 59
Naperville, IL 60563
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0554
outside of parameters of the orders, causing over- or under-dosing.
Level of Harm - Minimal harm
or potential for actual harm
On 8/24/2023 at 10:30 AM, R54's August 2023 POS (Physician Order Sheet) showed an order
for the menthol gel to be applied to the right shoulder, left knee and scapula, three times a day as
Residents Affected - Few
needed, for pain. R54's August 2023 POS also showed R54's order for the antifungal powder was
discontinued on 08/20/2023. R54's POS showed no orders to keep either medication at the
bedside.
2. R333's Face Sheet showed his diagnoses include chronic obstructive pulmonary disease and
muscle weakness. R333's 8/13/23 Minimum Data Set (MDS) showed he is cognitively intact.
On 08/22/23 at 12:24 PM, an albuterol metered-dose inhaler was on R333's desk. The inhaler
was visible from the doorway. R333 stated the inhaler was left by the nursing staff and was for
his use. The next day at 9:15 AM, R333's inhaler was again seen on his desk.
On 08/23/23 at 09:18 AM, V4 RN (Registered Nurse) stated as far as he knew, R333 was not
assessed for keeping medications at the bedside, he did not have orders to keep medications
there, and R333 did not have orders to self-administer his own medications.
On 08/24/23 at 09:57 AM, V2 DON (Director of Nursing) stated if residents do not have a
physicians order to keep medication at the bedside, then medication should be stored in the
medication cart and the nurse should be the only person to administer medication.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
146173
If continuation sheet
Page 2 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
146173
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/25/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Springs at Monarch Landing, The
2308 North Route 59
Naperville, IL 60563
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview and record review, the facility failed to ensure residents' medications were secured
and labeled.
This applies to 2 residents of 20 residents (R54, R333) reviewed for medication storage on the sample list
of 30.
Findings include:
1. R54's admission Record shows R54 was admitted on [DATE] and her diagnoses include gout, right
shoulder and left knee pain, and obsessive-compulsive disorder. R54's 12/03/2022 cognitive function care
plan showed she has impaired cognitive function related to a diagnosis of dementia, and her [Minimum
Data Set] (MDS) scoring does not reflect cognitive fluctuations and forgetfulness that is observed by staff.
On 08/22/2023 at 10:29 AM, R54 had an unlabeled tube of topical menthol pain reliever gel and an
antifungal powder container on her nightstand on the right side of her bed.
On 8/22/2023 at 10:30 AM, R54 said she regularly bought the menthol gel from an online retailer. R54 said
she ordered the medication so she can always have and use it when she wanted to. R54 said she uses the
gel on any part of her body that is hurting and she cannot remember how many times a day she uses it.
R54 said she uses the antifungal powder on her groin after going to the bathroom.
On 08/24/2023 at 09:55 AM, V2 (DON-Director of Nursing) said all medications are kept in the medication
carts or the medication room. V2 said all medications should be labeled and the facility does not allow
medication from outside sources. V2 said if unlabeled medications were found, they are returned to the
family and the facility will obtain physician orders and obtain the medication from facility's pharmacy.
On 8/24/2023 at 10:30 AM, R54's August 2023 POS (Physician Order Sheet) showed an order for the
menthol gel to be applied to the right shoulder, left knee and scapula, three times a day as needed, for
pain. R54's August 2023 POS also showed R54's order for the antifungal powder was discontinued on
08/20/2023. R54's POS showed no orders to keep either medication at the bedside.
Facility's November 2020 policy on Storage of Medications showed Policy heading: The facility stores all
drugs and biologicals in a safe, secure, and orderly manner. 1. Drugs and biologicals used in the facility are
stored in locked compartments . 3. The nursing staff is responsible for maintaining medication storage and
preparation areas in a clean, safe, and sanitary manner . 4. Drug containers that have missing, incomplete,
improper, or incorrect labels are returned to the pharmacy for proper labeling before storing. Discontinued,
outdated, or deteriorated drugs or biologicals are returned to the dispensing pharmacy or destroyed .
Facility's 1/29/2020 Policy on Labeling of Medication Containers showed .2. Any medication packaging or
containers that are inadequately or improperly labeled are returned to the issuing pharmacy. For
inadequately or improperly labeled medications from home or outside pharmacy, medication will be
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
146173
If continuation sheet
Page 3 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
146173
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/25/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Springs at Monarch Landing, The
2308 North Route 59
Naperville, IL 60563
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
returned to patient representative or back to patient at time of discharge . 4. Labels for over-the-counter
drugs include all necessary information, such as: a. The original label indicating the name, strength, and
quantity of the medication; b. The expiration date when aplicable; c. Directions for use and appropriate
accessory/cautionary statements
2. 1. R333's Face Sheet showed his diagnoses include chronic obstructive pulmonary disease and muscle
weakness. R333's 8/13/23 Minimum Data Set (MDS) showed he is cognitively intact.
On 08/22/23 at 12:24 PM, an albuterol metered-dose inhaler was on R333's desk. The inhaler was visible
from the doorway. R333 stated the inhaler was left by the nursing staff and was for his use. The next day
(8/23/23) at 9:15 AM, R333's inhaler was again seen on his desk.
On 08/23/23 at 09:18 AM, V4 RN (Registered Nurse) stated as far as he knew, R333 was not assessed for
keeping medications at the bedside, he did not have orders to keep medications there.
On 08/24/23 at 09:57 AM, V2 DON (Director of Nursing) stated if residents do not have a physicians order
to keep medication at the bedside, then medication should be stored in the medication cart.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
146173
If continuation sheet
Page 4 of 4